International Track 200

If cancer patients change position during radiotherapy treatment, Vision RT’s 3D imaging systems automatically pause the beam, helping to prevent damage to surrounding organs and tissues. Led by chief executive Norman Smith, 50, the London firm has more than 1,000 installations worldwide, helping exports reach £45.9m in 2018. Danish fund William Demant Invest bought a majority stake for an undisclosed sum that year. Last April, Vision RT acquired UK-based Aurora, a provider of facial recognition technology.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
Year2020
Rank169
CompanyVision RT
ActivityMedical technology developer
LocationNorth London
2-yr av intl sales growth pa34.05%
International sales £000s*45,875
Total sales £000s*48,646
Staff179
Founded2001
Websitewww.visionrt.com

If applicable:

* Supplied by company † Annualised figure